Agilent tours Asia Pacific region
Agilent tours Asia Pacific region; Instrumental analysis exhibition; Joint research and development agreement
Agilent tours Asia Pacific region
Agilent kicked off a world tour of the Asia Pacific region in Bejing (China) in March to showcase its new range of gas chromatography (GC) and gas chromatography–mass spectrometry (GC–MS) instruments. Since then, the tour has presented the new instruments' features to more than 4000 scientists in 50 cities.
Each country launched the new products with their own unique spin. There was a magic show in Korea, a seminar held at the Melbourne zoo, and a confetti cannon launch in Thailand featuring cheerleaders and quiz games.
The country manager for Greater China, Yi Ping Mu, opened the event in Bejing with an overview of Agilent's life sciences and chemical analysis (LSCA) business. This was followed by a talk by vice president for LSCA, Steve Leung, on the new 7890A GC and 5975C GC–MS with GC. Over 20 journalists attended the event.
The Korean leg of the tour started with a magician waving a multi-coloured, oversized flag and ring of fire, with the new GC appearing from a box. Customers were then given an overview of 7890A's proprietary capillary flow technology (CFT).
Similar events took place across Taiwan, Japan, Australia, Singapore, Malaysia and Thailand. India was the final stop of the tour and concentrated on Mumbai and Delhi.
Sui-Ching Low, Asia-Pacific marketing communications specialist at Agilent, said: "The region's fast economic growth is being led by China and India. The chromatography market in the region in general is driven by high growth, especially in high-end instrumentation as a result of an increase in R&D funding, as well as the governments' investments in academic research."
For more information about the company visit www.agilent.com
Instrumental analysis exhibition
The Beijing Conference and Exhibition on Instrumental Analysis (BCEIA) is a biennial event that will be held this year from 18–21 October. This event is sponsored by the China Association for Instrumental Analysis and is supported by the Ministry of Science and Technology (People's Republic of China).
The 12th BCEIA will be held at the Beijing Friendship Hotel (conference) and the Beijing Exhibition Centre (exhibition). The exhibition will take place at the same time as the conference.
The exhibition centre, with a total floor area of approximately 15000 m2, will house the exhibits of the recently developed analytical instruments, life science instruments, instruments for environmental protection, laboratory equipment, food analysis instruments and chemical reagents from all over the world. Associated technical seminars, business talks and an instrument development forum will be held simultaneously.
Additionally, a plenary session with six invited lectures and eight separate sessions for oral and poster presentations in the field of electron microscopy and material science, mass spectrometry, optical spectroscopy, chromatography, magnetic resonance, electroanalytical chemistry, analytical techniques in life sciences and environmental analysis will be featured.
For more information about this event visit the website at www.bceia.org
Joint research and development agreement
SGE Analytical Science has announced that it has entered into a Memorandum of Understanding under an Australian government Commercial Ready grant with Sydney-based Australian Proteome Analysis Facility (APAF).
APAF specializes in proteomics applications from early stage research through to protein biomarker discovery for its customers. SGE's liquid chromatography platform is suitable for use in many different proteomics applications. The companies plan to collaborate on the development and commercialization of new chromatography products, predominantly for the protein biomarker discovery markets.
APAF will publicise SGE's LC technologies under its services and skill training programmes to its customers and develop new ProteCol kits for a variety of applications. Once feasibility is established, customers can then purchase the kits directly from SGE and its OEM partners.
For more information visit SGE's website at www.sge.com
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Using Chromatography to Explore Fluorescent Bioactive Compounds in the Coelomic Fluid of Earthworms
February 6th 2025A study aiming to identify fluorescent bioactive compounds in the coelomic fluid of earthworms, as well as to investigate their structural and functional characteristics for possible use in biomedical applications, utilized a variety of chromatographic techniques.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
